Our goal for this study, was to demonstrate the advantages of using longitudinal data methods
Patients receiving chemotherapy frequently experience febrile neutropenia (FN), a dose-limiting toxicity that may disrupt planned chemotherapy administration (such as causing delays or dose reduction). This toxicity may necessitate hospitalization, which can be prolonged, costly, and may...
The UNC Gillings School of Global Public Health is doing something new. This fall for the first time, they are teaching a special topics course in pharmacovigilance as part of their pharmacoepidemiology curriculum.
Allen Mangel, MD, PhD, and Executive Vice President of RTI-HS, examines evidence that supports a different understanding of the behavior of the aorta during the cardiac cycle. Article published in J of Cardio Pharma.
Patient preference has the potential to inform a host of issues from initial device or drug development to post-marketing surveillance. While patient preference studies in health care research are becoming common, their use in regulatory decision making is relatively new.
Several members of the RTI-HS team recently attended the National Institute for Health and Care Excellence (NICE) 2017 conference in Liverpool, UK—a valuable way for our team to stay abreast of updates and ensure we have the appropriate understanding to guide our clients through the ever-...
The risks associated with respiratory syncytial virus (RSV) in newborns are generally well known. Parents of infants – particularly babies who were born prematurely – are routinely educated on precautions to protect their newborns against exposure, and pediatricians are vigilant about...
Recent law updates medical device regulation in the US. In the EU - greater transparency in post-market follow-up.
This comprehensive guide to the methods for preparing budget-impact analyses that adhere to published guidelines is a must have for the builder and budget holder.
The first of its kind for budget-impact analysis,
As part of a post-approval safety commitment to the U.S.
Research conducted to test the real-world feasibility and value of the BEDS-7 screening tool has recently been published in The Primary Care Companion for CNS Disorders.
RTI Health Solutions is pleased to announce that Ken Rothman, DrPH, Distinguished Fellow and Vice President for Epidemiology Research, has been awarded the Career Accomplishment Award by the Society for Epidemiologic Research (SER). Rothman received a plaque to commemorate the award on June 22nd...
RTI Health Solutions is honored to have staff that are leaders in research and academia. Our researchers often serve on industry advisory boards and teach at universities and industry sponsored courses. Dr. Susana Perez-Gutthann, Vice President and Global Head of Epidemiology, recently...
Research currently relies mostly on pregnancy exposure registries to gather data for safety studies once drugs are on the market. RTI Health Solutions researchers believe that, for many of those studies, there is a better way to collect that data.
Nepafenac is a non-steroidal anti-inflammatory drug approved to treat pain and inflammation in the first 2 weeks following cataract surgery in adults. In 2016, a new indication for this drug was approved – prevention of postoperative macular edema in patients with diabetes for use up to 60 days...
RTI Health Solutions’ James Kaye has just returned from a very busy American Society of Clinical Oncology (ASCO) Annual Meeting. He shares these insights from that meeting.
To celebrate an ongoing commitment to high-quality, reliable research, several RTI International and RTI Health Solutions researchers were recognized May 16, 2017, for their published contributions at an RTI sponsored Authors’ Awards dinner.
At a recent workshop convened by the Duke-Margolis Center for Health Policy, Dana DiBenedetti, PhD, Executive Director of Patient-Centered Outcomes Assessment at RTI Health Solutions presented information concerning the use of interviews conducted as part of clinical trials as an emerging method...
On World IBD Day, RTI Health Solutions joins with organizations and individuals around the world to support those living with irritable bowel disease (IBD). RTI Health Solutions is committed to providing trusted research to aid the development of treatments.
When our cholesterol levels are where they should be, it’s good for our heart. When cholesterol levels are elevated, it increases the risk for coronary heart disease (CHD). The first line of defense is usually a change in diet. If that alone does not bring cholesterol levels to where they should...
Chronic obstructive pulmonary disease (COPD), a chronic lung disease, is debilitating and makes breathing difficult for those affected by it. Its impact on quality of life and health care costs is substantial.
Childhood asthma is a significant public health problem. Caregivers must identify and manage diverse environmental triggers and promote appropriate use of preventive asthma medications.
In a time of rapidly transforming communication technologies, developers and researchers are creating new ways to track and combat disease. A new book presents an integrated look at the methods that are shaping the use of communication technology in health care.
As the number of treatments available for relapsing multiple sclerosis (RMS) grows, evaluating patient treatment preferences can help in understanding the potential value of treatments.